Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Stockholders Equity Over TimeExpanding
Percentile Rank100
3Y CAGR+21.2%
5Y CAGR+15.7%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
+21.2%/yr
Annual compound
5Y CAGR
+15.7%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $343.43M | +53.0% |
| 2024 | $224.53M | +14.0% |
| 2023 | $196.99M | +2.1% |
| 2022 | $192.90M | +15.7% |
| 2021 | $166.73M | +0.5% |
| 2020 | $165.98M | +2864.0% |
| 2019 | $-6.00M | -343.5% |
| 2018 | $-1.35M | - |